Aeglea Biotherapeutics, Inc. (AGLE) Files Form 4 Insider Buying : Anthony Quinn Buys 10,000 Shares

Aeglea Biotherapeutics, Inc. (AGLE): Anthony Quinn , director of Aeglea Biotherapeutics, Inc. purchased 10,000 shares on Apr 12, 2016. The Insider buying transaction was reported by the company on Apr 12, 2016 to the Securities and Exchange Commission. The shares were purchased at $10.00 per share for a total value of $100,000.00 according the SEC Form 4 Filing.

Leave a Reply

Aeglea Biotherapeutics, Inc. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Aeglea Biotherapeutics, Inc.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.